Constitutive IP


Journal

Cell death and differentiation
ISSN: 1476-5403
Titre abrégé: Cell Death Differ
Pays: England
ID NLM: 9437445

Informations de publication

Date de publication:
03 2019
Historique:
received: 30 07 2017
accepted: 16 05 2018
revised: 15 05 2018
pubmed: 15 6 2018
medline: 4 6 2020
entrez: 15 6 2018
Statut: ppublish

Résumé

Anti-apoptotic Bcl-2 proteins are upregulated in different cancers, including diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL), enabling survival by inhibiting pro-apoptotic Bcl-2-family members and inositol 1,4,5-trisphosphate (IP

Identifiants

pubmed: 29899382
doi: 10.1038/s41418-018-0142-3
pii: 10.1038/s41418-018-0142-3
pmc: PMC6370760
doi:

Substances chimiques

BCL2 protein, human 0
BIRD-2 peptide 0
Inositol 1,4,5-Trisphosphate Receptors 0
Peptides 0
Proto-Oncogene Proteins c-bcl-2 0
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

531-547

Références

Oncotarget. 2015 Sep 29;6(29):27388-402
pubmed: 26317541
Cell Death Differ. 2012 Feb;19(2):295-309
pubmed: 21818117
Mol Cell. 2008 Jul 25;31(2):255-65
pubmed: 18657507
Nat Rev Drug Discov. 2013 Mar;12(3):229-43
pubmed: 23449308
J Biol Chem. 1994 Aug 26;269(34):21691-8
pubmed: 8063813
Trends Biochem Sci. 2016 May;41(5):390-393
pubmed: 27068804
J Cell Sci. 2009 Feb 15;122(Pt 4):437-41
pubmed: 19193868
Apoptosis. 2007 May;12(5):951-68
pubmed: 17294082
Blood. 2011 Mar 10;117(10):2924-34
pubmed: 21193695
Nat Rev Drug Discov. 2008 Dec;7(12):989-1000
pubmed: 19043450
Int J Dev Biol. 2015;59(7-9):391-8
pubmed: 26260683
Biochim Biophys Acta. 2014 Oct;1843(10):2164-83
pubmed: 24642269
Oncotarget. 2017 Dec 4;8(67):111656-111671
pubmed: 29340082
Nature. 2012 Sep 13;489(7415):309-12
pubmed: 22885698
Biochem Biophys Res Commun. 2008 Oct 31;375(4):501-5
pubmed: 18723000
J Cell Biol. 2004 Jul 19;166(2):193-203
pubmed: 15263017
Cell Rep. 2016 Mar 15;14(10):2313-24
pubmed: 26947070
Oncotarget. 2016 Aug 23;7(34):55704-55720
pubmed: 27494888
Cell Death Dis. 2013 May 16;4:e632
pubmed: 23681227
J Biol Chem. 1995 May 12;270(19):11678-83
pubmed: 7744807
J Cell Biol. 2006 Jun 5;173(5):755-65
pubmed: 16754959
Biochim Biophys Acta. 2015 Sep;1853(9):1992-2005
pubmed: 25499268
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14397-402
pubmed: 19706527
Nat Med. 2013 Feb;19(2):202-8
pubmed: 23291630
Cell Death Dis. 2012 May 03;3:e304
pubmed: 22552281
Cell Death Dis. 2010 May 06;1:e40
pubmed: 21364647
Front Oncol. 2017 May 03;7:75
pubmed: 28516063
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12420-5
pubmed: 23840064
Cell Death Dis. 2015 Dec 31;6:e2034
pubmed: 26720343
Biochim Biophys Acta Mol Cell Res. 2017 Jun;1864(6):968-976
pubmed: 27913204
Neoplasia. 2018 May;20(5):510-523
pubmed: 29626751
Biochim Biophys Acta. 2011 May;1813(5):1003-13
pubmed: 21146562
Oncogene. 2016 Sep 29;35(39):5079-92
pubmed: 26973249
Br J Haematol. 2003 Apr;121(1):97-100
pubmed: 12670337
Biochim Biophys Acta. 2016 Jun;1863(6 Pt B):1364-78
pubmed: 26772784
J Clin Oncol. 2017 Mar 10;35(8):826-833
pubmed: 28095146
J Biol Chem. 1985 Mar 25;260(6):3440-50
pubmed: 3838314
Cancer Cell. 2007 Aug;12(2):171-85
pubmed: 17692808
Hepatology. 2005 Apr;41(4):868-78
pubmed: 15732085
Biochem Pharmacol. 2001 Apr 1;61(7):803-9
pubmed: 11274965
Physiol Rev. 2007 Apr;87(2):593-658
pubmed: 17429043
Oncotarget. 2015 May 30;6(15):12862-71
pubmed: 25970783
Nat Rev Cancer. 2008 Feb;8(2):121-32
pubmed: 18202696
Nature. 2010 Jan 7;463(7277):88-92
pubmed: 20054396
Autophagy. 2011 Dec;7(12):1472-89
pubmed: 22082873
Oncogene. 2017 Jun 29;36(26):3651-3660
pubmed: 28192408
Haematologica. 2017 Sep;102(9):1469-1476
pubmed: 28775118
Cell Death Differ. 2013 Dec;20(12):1631-43
pubmed: 23811847
J Biol Chem. 2002 Mar 8;277(10):8106-13
pubmed: 11741904
Blood. 2012 Oct 25;120(17):3501-9
pubmed: 22955911

Auteurs

Mart Bittremieux (M)

Lab. Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut, KU Leuven, Leuven, Belgium.

Rita M La Rovere (RM)

Lab. Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut, KU Leuven, Leuven, Belgium.

Haidar Akl (H)

Lab. Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut, KU Leuven, Leuven, Belgium.
Department of Biology, Lebanese University, Hadath, Lebanon.

Claudio Martines (C)

Molecular Hematology Unit, ICGEB, Trieste, Italy.

Kirsten Welkenhuyzen (K)

Lab. Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut, KU Leuven, Leuven, Belgium.

Kathia Dubron (K)

Lab. Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut, KU Leuven, Leuven, Belgium.

Myriam Baes (M)

Cell Metabolism, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

Ann Janssens (A)

Department of Hematology, UZ Leuven, Leuven, Belgium.

Peter Vandenberghe (P)

Department of Hematology, UZ Leuven, Leuven, Belgium.
Department of Human Genetics, KU Leuven, Leuven, Belgium.

Luca Laurenti (L)

Università Cattolica del Sacro Cuore, Fondazione Policlinico A. Gemelli, Rome, Italy.

Katja Rietdorf (K)

School of Life, Health and Chemical Sciences, The Open University, Milton Keynes, UK.

Giampaolo Morciano (G)

Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology and LTTA center, University of Ferrara, Ferrara, Italy.
GVM Care & Research, Maria Pia Hospital, Torino, Italy.
GVM Care & Research, Maria Cecilia Hospital, Cotignola, Italy.

Paolo Pinton (P)

Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology and LTTA center, University of Ferrara, Ferrara, Italy.
GVM Care & Research, Maria Cecilia Hospital, Cotignola, Italy.

Katsuhiko Mikoshiba (K)

The Laboratory for Developmental Neurobiology, Brain Science Institute, RIKEN, Wako, Saitama, Japan.

Martin D Bootman (MD)

School of Life, Health and Chemical Sciences, The Open University, Milton Keynes, UK.

Dimitar G Efremov (DG)

Molecular Hematology Unit, ICGEB, Trieste, Italy.

Humbert De Smedt (H)

Lab. Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut, KU Leuven, Leuven, Belgium.

Jan B Parys (JB)

Lab. Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut, KU Leuven, Leuven, Belgium.

Geert Bultynck (G)

Lab. Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine and Leuven Kanker Instituut, KU Leuven, Leuven, Belgium. geert.bultynck@kuleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH